Pfizer, Inc. News

Do you have an interest in the products developed by Pfizer, Inc., or are you interested in the performance of the company? If you are you should register for the free Pfizer, Inc. news email from Wiser. Pfizer, Inc. is an American-based pharmaceutical company that researches, develops and manufactures medicines and vaccines. The products developed by the company are used all over the world. They include leading brands like Lipitor, Zithromax and Viagra. The company was founded in 1849 and today is one of the largest pharmaceutical companies in the world. Its current chairman and CEO is Ian Reed. Most analysts expect Pfizer, Inc. to expand through acquisitions over the coming years. The Wiser daily Pfizer, Inc. news email covers this news as well as analysis on the performance of the company, and details about its products. These articles come from the best sources around the web and are delivered in a comprehensive but simple to use format. Sign up today.

Recent Pfizer, Inc. News Coverage
 
Your Weekly Recommendations Monday, March 27, 2017
 
Recommended for you
Chinese drug approval boosts AstraZeneca's lung cancer hopes
Reuters
Pro Portfolio Proof II: David Katz 'Safer' Value Portfolio Picks
Seeking Alpha • Fredrik Arnold
With Healthcare Now Off Trump's Agenda, It's Time To Dive Into The Sector
Seeking Alpha • Orange Peel Investments
Fifth Portfolio Review - 'The Accelerated Dividend Portfolio'
Seeking Alpha • Clearview60
Drug commercials, like prescription costs, are on the rise
PBS • Nsikan Akpan
Corporate Venture Capital - Savior Of Medtech?
Seeking Alpha • E.P. Vantage
Corporate Venture Capital - Savior Of Medtech?
Seeking Alpha • E.P. Vantage
Brainstorm Health Daily: March 20, 2017
Fortune Magazine • Clifton Leaf, Sy Mukherjee
Gemphire Therapeutics: A Cheap Biotech With Several Catalysts Coming
Seeking Alpha • Jonathan Faison
Gemphire Therapeutics: A Cheap Biotech With Several Catalysts Coming
Seeking Alpha • Jonathan Faison
 
Recommended for You
Cancer, Epidemiology
Chinese drug approval boosts AstraZeneca's lung cancer hopes
Reuters
LONDON (Reuters) - AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.
Share
Finance, Investment Industry
Pro Portfolio Proof II: David Katz 'Safer' Value Portfolio Picks
Seeking AlphaFredrik Arnold
Summary Four methods can gauge the dividend safety of equities: (1) Free cash-flow yields; (2) cash dividend payout-ratios; (3) 1-year. Positive one-year returns narrowed 78 equities from David Katz's portfolio (from YCharts) to 42. A sort for free cash-flow yields greater than...
Share
Electronic Components, Health Finance
With Healthcare Now Off Trump's Agenda, It's Time To Dive Into The Sector
Seeking AlphaOrange Peel Investments
Summary GOP failed to pass their healthcare bill last week. Comments from Paul Ryan make it seem as though healthcare is off the agenda for a while. Pricing concerns should fade away, leaving healthcare companies to conduct business as usual for the...
Share
Finance, Investment Industry
Fifth Portfolio Review - 'The Accelerated Dividend Portfolio'
Seeking AlphaClearview60
Summary Bought additional shares in Hercules Capital at a total cost of $14.65 per share. As promised last month, I provide some sage advice from the late, great Benjamin Graham from his book titled "The Intelligent Investor". It's been 28 months since...
Share
Advertising Industry, CBS Broadcasting Inc
Drug commercials, like prescription costs, are on the rise
PBSNsikan Akpan
A screenshot from an ad by Pfizer, the maker of Lyrica. Photo by iSpot.tv Laura Ries was moved to action when she saw a TV commercial that portrayed a woman enjoying time with her grandchildren after taking Lyrica, a prescription medication for...
Share
Finance, Investment Industry
Corporate Venture Capital - Savior Of Medtech?
Seeking AlphaE.P. Vantage
Big medtech and big pharma are taking a greater role in the funding of medical device start-ups. 2016 was the first year in which the corporate venture arms of the large strategics have put up more than 20% of the cash for...
Share
Finance, Health Finance
Corporate Venture Capital - Savior Of Medtech?
Seeking AlphaE.P. Vantage
Big medtech and big pharma are taking a greater role in the funding of medical device start-ups. 2016 was the first year in which the corporate venture arms of the large strategics have put up more than 20% of the cash for...
Share
Electronic Health Records, Health IT
Brainstorm Health Daily: March 20, 2017
Fortune MagazineClifton Leaf, Sy Mukherjee
Good morning, readers. This is Sy. As Cliff mentioned last week, I'll be taking over for him until next Tuesday, March 28, when he gets back from vacation. It's no surprise that digital health startups are often staffed with tech experts who...
Share
Health Finance, Pfizer, Inc.
Gemphire Therapeutics: A Cheap Biotech With Several Catalysts Coming
Seeking AlphaJonathan Faison
Summary Shares have traded relatively flat since the company's initial public offering. Share price could runup into three data readouts from phase 2b trials. Principal asset gemcabene appears to have a differentiated profile that could allow the company to carve its niche...
Share
Pfizer, Inc.
Gemphire Therapeutics: A Cheap Biotech With Several Catalysts Coming
Seeking AlphaJonathan Faison
Summary Shares have traded relatively flat since the company's initial public offering. Share price could runup into three data readouts from phase 2b trials. Principal asset gemcabene appears to have a differentiated profile that could allow the company to carve its niche...
Share